Scinai Immunotherapeutics Closes $4.0 Million Private Placement and Warrant Inducement
Scinai Immunotherapeutics said it closed a $4.0 million financing through a private placement and warrant inducement.
Story updates
12:01:16 PM UTC
SquawkNews
Scinai closed a private placement of 2,458,334 ADSs with Series A-1 warrants and an immediate exercise of existing warrants, for aggregate gross proceeds of approximately $4.0M.Material DetailsContext by AI AnalystThis funding continues a shift toward CDMO-driven cash generation alongside an immuno…
JERUSALEM, Oct. 16, 2026 // -- Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) ("Scinai" or the "Company"), a biopharmaceutical company operating a growing contract development and manufacturing organization ("CDMO") alongside an immunology-focused therapeutic development platform, today ann…